Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 21;12(11):1123.
doi: 10.3390/pharmaceutics12111123.

Insights into the Binding of Dietary Phenolic Compounds to Human Serum Albumin and Food-Drug Interactions

Affiliations
Review

Insights into the Binding of Dietary Phenolic Compounds to Human Serum Albumin and Food-Drug Interactions

Anallely López-Yerena et al. Pharmaceutics. .

Abstract

The distribution of drugs and dietary phenolic compounds in the systemic circulation de-pends on, among other factors, unspecific/specific reversible binding to plasma proteins such as human serum albumin (HSA). Phenolic substances, present in plant-derived feeds, foods, beverages, herbal medicines, and dietary supplements, are of great interest due to their biological activity. Recently, considerable research has been directed at the formation of phenol-HSA complexes, focusing above all on structure-affinity relationships. The nucleophilicity and planarity of molecules can be altered by the number and position of hydroxyl groups on the aromatic ring and by hydrogenation. Binding affinities towards HSA may also differ between phenolic compounds in their native form and conjugates derived from phase II reactions. On the other hand, food-drug interactions may increase the concentration of free drugs in the blood, affecting their transport and/or disposition and in some cases provoking adverse or toxic effects. This is caused mainly by a decrease in drug binding affinities for HSA in the presence of flavonoids. Accordingly, to avoid the side effects arising from changes in plasma protein binding, the intake of flavonoid-rich food and beverages should be taken into consideration when treating certain pathologies.

Keywords: bioavailability; distribution; molecular property; noncovalent interaction; pharmacokinetics; plasma protein binding.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Figures

Figure 1
Figure 1
Chemical structure of flavonoids.
Figure 2
Figure 2
Chemical structure of representative phenolic acids. General chemical structure of stilbenes and hydrolysable tannins.
Figure 3
Figure 3
Dietary flavonoid–drug interaction mechanism.

Similar articles

Cited by

References

    1. Xiao J., Kai G. A review of dietary polyphenol-plasma protein interactions: Characterization, influence on the bioactivity, and structure-affinity relationship. Crit. Rev. Food Sci. Nutr. 2012;52:85–101. doi: 10.1080/10408398.2010.499017. - DOI - PubMed
    1. Ribas-Agustí A., Martín-Belloso O., Soliva-Fortuny R., Elez-Martínez P. Food processing strategies to enhance phenolic compounds bioaccessibility and bioavailability in plant-based foods. Crit. Rev. Food Sci. Nutr. 2018;58:2531–2548. doi: 10.1080/10408398.2017.1331200. - DOI - PubMed
    1. Poloni D.M., Dangles O., Vinson J.A. Binding of plant polyphenols to serum albumin and LDL: Healthy implications for heart disease. J. Agric. Food Chem. 2019;67:9139–9147. doi: 10.1021/acs.jafc.8b06674. - DOI - PubMed
    1. FDA G. Bioavailability and Bioequivalence Studies for Orally Administered Drug Products—General. Food and Drug Administration; Rockville, MD, USA: 2002.
    1. Neilson A.P., Goodrich K.M., Ferruzzi M.G. Nutrition in the Prevention and Treatment of Disease. Elsevier; Amsterdam, The Netherlands: 2017. Bioavailability and Metabolism of Bioactive Compounds from Foods; pp. 301–319.
-